NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/04/2022
Back to search
Official data from USPTO
ENDSULIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/04/2022
Trademark type
Word
Nice classes
5, 44
Filing date
03/01/2021
Registration date
10/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2022
Last transaction
10/04/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/05/2022
First use in commerce
04/05/2022
Drawing code
4
Owner type
03
Owner location
Madison, WI
Examiner
RAFARI-PEARSON, NIYA
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Endsulin, Inc.
Representatives
Laura M. Konkel MICHAEL BEST & FRIEDRICH LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for treating diabetes
Class 44
Provision of gene therapy for medical purposes in the nature of gene therapy medical services; medical services; medical services for the treatment of diabetes
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/19/2022
PUBO
PUBLISHED FOR OPPOSITION
07/19/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/11/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/10/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/09/2022
GNFR
FINAL REFUSAL E-MAILED
05/09/2022
CNFR
FINAL REFUSAL WRITTEN
05/09/2022
IUAA
USE AMENDMENT ACCEPTED
05/09/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/07/2022
IUAF
USE AMENDMENT FILED
04/07/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2022
ALIE
ASSIGNED TO LIE
03/24/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/24/2021
GNRT
NON-FINAL ACTION E-MAILED
09/24/2021
CNRT
NON-FINAL ACTION WRITTEN
09/24/2021
DOCK
ASSIGNED TO EXAMINER
09/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/29/2021
NWAP
NEW APPLICATION ENTERED
03/04/2021
Continuous trademark protection
Get notified about every new filing that threatens ENDSULIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.